Literature DB >> 23072716

Impact of diagnostic criteria on the prevalence of COPD.

Yunus Çolak1, Anders Løkke, Jacob Louis Marott, Peter Lange, Jørgen Vestbo.   

Abstract

INTRODUCTION: The reduction in the ratio between forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) is used for the diagnosis of chronic obstructive pulmonary disease (COPD). The choice between a simple fixed cut-off ratio (FEV1/FVC <0.70) and the use of lower limit of normal (LLN) is eagerly discussed. The aim of this paper was to examine the impact of these two diagnostic measures on the prevalence of COPD using data from the fourth examination of The Copenhagen City Heart Study (CCHS4). MATERIALS AND
METHODOLOGY: A total of 6237 subjects participated in CCHS4 from 2001 to 2003. Asymptomatic, healthy never-smokers of all ages with adequate information from questionnaires and spirometry were used to calculate LLN.
RESULTS: LLN was declining with increasing age and height. If LLN was used as the correct diagnostic criterion, under- and over-diagnosis among men were 0.4% and 7.0%, respectively, and for women 2.0% and 1.4%, respectively, when using the fixed ratio. Over-diagnosis among men was reduced from 7.0% to 3.0% by changing the fixed cut-off ratio to FEV1/FVC <0.65 for subjects older than 65 years. Among women, however, this adjustment led to an increase in under-diagnosis from 2.0% to 5.7%. Most participants with FEV1/FVC <0.70 but >LLN had well-preserved FEV1.
CONCLUSION: Using the fixed ratio for diagnosing COPD in an epidemiological setting results in a higher prevalence than if the LLN is used. Time seems ripe for studying if the same is seen when diagnosing COPD in the clinical setting.
© 2012 John Wiley & Sons Ltd.

Entities:  

Keywords:  COPD; FEV1/FVC; LLN; diagnosis; epidemiology; lower limit of normal; spirometry

Mesh:

Year:  2012        PMID: 23072716     DOI: 10.1111/crj.12007

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  5 in total

1.  The impact of different spirometric definitions on the prevalence of airway obstruction and their association with respiratory symptoms.

Authors:  Howraman Meteran; Martin R Miller; Simon Francis Thomsen; Kaare Christensen; Torben Sigsgaard; Vibeke Backer
Journal:  ERJ Open Res       Date:  2017-12-08

Review 2.  European Respiratory Society International Congress 2018: four shades of epidemiology and tobacco control.

Authors:  Maaike de Vries; Eleanor L Axson; Jate Ratanachina; Orianne Dumas; Sara De Matteis; Annabelle Bédard; Célina Roda; Subhabrata Moitra; Elif Dagli; Athina Dimanti; Asli Gorek Dilektasli; Sofia Ravara; André F S Amaral
Journal:  ERJ Open Res       Date:  2019-03-04

3.  Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease.

Authors:  Yong Suk Jo; Kyung Joo Kim; Chin Kook Rhee; Kwang Ha Yoo; Ki-Suck Jung; Yong-Bum Park
Journal:  Respir Res       Date:  2022-08-22

4.  Lung function in Lolland-Falster Health Study (LOFUS).

Authors:  Katja Kemp Jacobsen; Randi Jepsen; Uffe Bodtger; Knud Rasmussen; Gry St-Martin
Journal:  Clin Respir J       Date:  2022-09-02       Impact factor: 1.761

5.  Association between dual use of e-cigarette and cigarette and chronic obstructive pulmonary disease: an analysis of a nationwide representative sample from 2013 to 2018.

Authors:  Taeyun Kim; Jihun Kang
Journal:  BMC Pulm Med       Date:  2021-07-13       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.